In addition to the above-mentioned statement, a study by Moosavi [110] found that overexpression of AQP1, AQP3, and AQP5 is inextricably linked to carcinogenesis, metastasis, decreased survival rate, lymph node metastasis, a worse prognosis, and cellular migration and that furthermore, cancer therapies associated with these markers suggest AQP decreases during treatment. Here, AQP1 is linked to metastatic malignant neoplasm in the lymph nodes.